Antibody Analytics is teaming with Science Exchange to offer its surface plasmon resonance services to a global research community.

A trio of aging-focused biotechs and research firms formed a joint venture to develop small molecules for a novel target hoping to extend life spans.

Charles River Labs reported that second-quarter revenues soared 24.8% on support from recent acquisitions and a favorable foreign currency environment.

Syneos Health, a combo CRO/CCO, said it plans to make a secondary stock offering of 6 million shares priced to the public at $50.15 per share.

Novartis will partner with Albumedix to explore using the company’s technology as a possible drug delivery platform for several therapies.

Clinical research helper WIRB-Copernicus Group has acquired KMR Group and Metrics Consortium to bolster its market insights and intelligence division.

Healx has reeled in $10 million in series A funding it plans to use to hire more researchers and enhance its AI platform.

Pharma giant Novartis has signed Shyft, a Medidata Solutions subsidiary, to help strengthen its digital solutions.